Market Overview - The Shanghai and Shenzhen stock markets showed mixed performance on September 2, with the Shanghai Composite Index slightly up at the open, while the Shenzhen Component and ChiNext Index opened lower. By midday, all indices experienced significant declines [1] - The Shanghai Composite Index closed at 3844.84 points, down 0.79%, with a trading volume of approximately 811.7 billion yuan. The Shenzhen Component Index closed at 12545.82 points, down 2.21%, with a trading volume of about 1.1 trillion yuan. The ChiNext Index closed at 2870.72 points, down 2.90%, with a trading volume of around 529.2 billion yuan [1] Sector Performance - Sectors such as industrial mother machines, brain engineering, non-ferrous metals, aviation, and electricity showed strong performance at the market open. Precious metals, solid-state batteries, and innovative pharmaceuticals also performed well initially [1] - However, sectors like CPO concepts, communication equipment, copper cable high-speed connections, liquid cooling concepts, electronic components, and digital currencies experienced significant adjustments during the early trading session [1] Institutional Insights - CITIC Securities suggests that the market style will maintain high-level fluctuations, focusing on domestic and international computing power themes. The second half of the year is typically a period of intensive technology releases and product iterations in the domestic technology sector [2] - China Galaxy Securities notes that A-shares have a lower absolute valuation compared to U.S. stocks, indicating significant room for improvement. Certain sectors like finance and transportation infrastructure still hold valuation advantages, presenting structural opportunities [2] - GF Securities expresses optimism about the real estate sector's potential for recovery, highlighting September as a crucial window for decision-making in real estate allocation [2] Policy Developments - The State-owned Assets Supervision and Administration Commission (SASAC) emphasizes the acceleration of the development of the central enterprise biopharmaceutical industry, aiming to create a national team in the biopharmaceutical field to promote high-quality development [3] - The National Standardization Administration and the Ministry of Industry and Information Technology have issued a plan to establish a high-quality standard system for industrial mother machines by 2026, aiming to enhance product quality and equipment upgrades [4] - Shenzhen has introduced regulations to promote the innovative development of the synthetic biology industry, focusing on creating a market-oriented and application-predictable industrial system [5][6]
午评：主要股指显著调整 贵金属股领涨 CPO概念股领跌
Xin Hua Cai Jing·2025-09-02 05:15